Survey on satisfaction of young adults receiving cancer treatment in different infusion spaces
Official title: Young Adult Infusion Space Survey: Comparing Experiences of Adolescents and Young Adults in Infusion Spaces at North Carolina Basnight Cancer Hospital
Run by UNC Lineberger Comprehensive Cancer Center · NCT05720546 · Data updated 2026-11-12
This study is trying to see how satisfied young adults aged 18-39 are with their cancer treatment experiences in different infusion spaces at a hospital.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 39 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | UNC Lineberger Comprehensive Cancer Center Academic / other |
| Locations | 1 site (Chapel Hill, North Carolina) |
| Status | Recruiting |
| Started | February 20, 2023 |
| Main results expected | July 28, 2027 |
| Study ends | July 28, 2027 |
| Registry record updated | November 2, 2026 |
| Trial ID | NCT05720546 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are English-speaking young adults aged 18-39 who are currently receiving treatment for cancer.
✕Probably not a fit
Patients with dementia, altered mental status, or psychiatric conditions that impair their ability to provide informed consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the satisfaction levels of Adolescent and Young Adults (AYA) aged 18-39 who are undergoing cancer treatment at the North Carolina Basnight Cancer Hospital. Participants will complete surveys and engage in semi-structured interviews to evaluate their experiences in two distinct infusion environments, focusing on aspects such as the built environment and interactions with mental health staff. The findings will help identify differences in patient satisfaction between the outpatient infusion spaces.
Why it matters
Potential benefit: If successful, this study could enhance the treatment experience for young adults with cancer by informing improvements in infusion space design and support services.
How similar studies have gone: While there may be studies focusing on patient satisfaction in healthcare settings, this specific approach targeting AYA cancer patients in infusion spaces is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Written informed consent obtained to participate in the study and HIPAA authorization for the release of personal health information. 2. Subjects are willing and able to comply with study procedures based on the judgment of the investigator or protocol designee. 3. Age 18-39 years old at enrollment. 4. Receiving treatment for a cancer diagnosis in Adult Infusion Center or the Adolescent and Young Adult Infusion Center 5. English speaking. Exclusion Criteria: 1. Dementia, altered mental status, or any psychiatric condition as determined by the clinical or study team that would prohibit the understanding or rendering of informed consent. 2. Current incarceration.
Where it's running
-
UNC Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States Recruiting
Study contacts
- Principal investigator: Jacob Stein — UNC Lineberger Comprehensive Cancer Center
- Study coordinator: Hannah Auddino
- Email: Hannah_Auddino@med.unc.edu
- Phone: 919-928-6231
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
-
Compare a new endoscopy-assisted breast-conserving surgery with the usual approach
This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
-
3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy
This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.